- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 251/32 - Oximes
Patent holdings for IPC class C07C 251/32
Total number of patents in this class: 23
10-year publication summary
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ambrx, Inc. | 166 |
3 |
| University of Southampton | 465 |
2 |
| BASF SE | 21320 |
1 |
| The Regents of the University of California | 20902 |
1 |
| AstraZeneca AB | 2823 |
1 |
| AstraZeneca UK Limited | 510 |
1 |
| Syngenta Crop Protection AG | 6756 |
1 |
| Advansix Resins & Chemicals LLC | 307 |
1 |
| Council of Scientific and Industrial Research | 600 |
1 |
| GE Healthcare Limited | 628 |
1 |
| Guangzhou Magpie Pharmaceutical Co., Ltd | 1 |
1 |
| Kyung Nong Corporation | 16 |
1 |
| Oak Ridge National Laboratory | 3 |
1 |
| Screen Holdings Co., Ltd. | 3245 |
1 |
| Universidad de Leon | 26 |
1 |
| Universidad Publica de Navarra | 48 |
1 |
| The University of Melbourne | 572 |
1 |
| University of Tennessee Research Foundation | 765 |
1 |
| Universidad del Pais Vasco-Euskal Herriko Unibertsitatea | 116 |
1 |
| Recurium IP Holdings, LLC | 125 |
1 |
| Other owners | 0 |